Know Labs expands board to 7 with three new directors from IP and diabetes sectors

USBC, Inc.

John Cronin, Larry Ellingson, and Timothy Londergan appointed as independent directors effective Nov 3, 2023.
Cronin helped boost Know Labs' patent portfolio from 86 to 246 issued, pending or in-process patents in 12 months.
Ellingson, former Eli Lilly diabetes head, served on Know Labs' advisory board for 4 years prior.
Londergan, CEO of Tangibly, was named IAM 300 World's Leading IP Strategist 2023.
New directors receive annual stock option grants and cash retainer of $10,000–$12,500.

item 5.02 item 7.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

John Cronin

Director

USBC · USBC, Inc.

Effective: 2023-11-03
Filed: November 8, 2023, 6:59 PM ET

On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.

Appointed

Larry K. Ellingson

Director

USBC · USBC, Inc.

Effective: 2023-11-03
Filed: November 8, 2023, 6:59 PM ET

On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.

Appointed

Timothy M. Londergan

Director

USBC · USBC, Inc.

Effective: 2023-11-03
Filed: November 8, 2023, 6:59 PM ET

On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

John Cronin was appointed as Director at USBC, Inc..

Action: appointed
Role: Director

Exact text from the filing

On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Larry K. Ellingson was appointed as Director at USBC, Inc..

Action: appointed
Role: Director

Exact text from the filing

On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Timothy M. Londergan was appointed as Director at USBC, Inc..

Action: appointed
Role: Director

Exact text from the filing

On November 3, 2023, the Board of Directors (“Board”) of Know Labs, Inc. (the “Company”) appointed Larry K. Ellingson, John Cronin and Timothy M. Londergan, as new non-employee members of the Board.

View on SEC.gov

USBC, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-23-013894

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.